1. Department of Health and Human Services. Office of Inspector General.Postmarketing Studies of Prescription Drugs. May1996. OEI‐03‐94‐00760 p.11.http://oig.hhs.gov/oei/reports/oei‐03‐94‐00760.pdf(accessed April 2019).
2. A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary;Humphries TJ;Am J Gastroenterol,1984
3. The role of the FDA in the effort against AIDS;Young FE;Public Health Rep,1988
4. The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium vs. other nonsteroidal antiinflammatory drugs;Strom BL;J Rheumatol,1988